Drug Type Small molecule drug |
Synonyms Theophylline sodium glycinate (USP), Asbron, Synophylate |
Target |
Action antagonists, inhibitors |
Mechanism A1R antagonists(Adenosine A1 receptor antagonists), A2bR antagonists(Adenosine A2b receptor antagonists), PDE inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (17 Oct 1947), |
Regulation- |
Molecular FormulaC9H13N5NaO4 |
InChIKeyCYQWSJWKWVOUDG-UHFFFAOYSA-N |
CAS Registry8000-10-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | China | 01 Jan 1995 | |
Bronchitis | China | 01 Jan 1995 | |
Pulmonary Edema | China | 01 Jan 1995 |